JacquelineSGarciaMD

PubMed

• Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes.
  Jacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, Shaun A Fleming, Chun Yew Fong
  Blood. 2024-12-09
• Venetoclax plus low intensity chemotherapy for adults with acute lymphoblastic leukemia.
  Marlise R Luskin, Shai Shimony, Julia H Keating, Eric S Winer, Jacqueline S Garcia
  Blood Advances. 2024-11-15
• 1 citations
  A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.
  Joost B Koedijk, Inge van der Werf, Livius Penter, Marijn A Vermeulen, Farnaz Barneh
  Leukemia. 2024-11-01

Journal Articles

• Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia  
  Courtney D Dinardo, Brian A Jonas, Jacqueline S Garcia, Anthony Letai, Wan-Jen Hong, Keith W Pratz, The New England Journal of Medicine

Abstracts/Posters

• Talazoparib Treatment Preferentially Depletes Cohesin-Mutant Clones in New In Vivo Models of Cohesin-Mutant Myeloid Diseases
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Individualized Mitochondrial Functional Approach to Combination of BCL-2 and MCL-1 Antagonism in Acute Myeloid Leukemia
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Sleep Disturbance Among Patients with Myelodysplastic Syndromes and Acute Leukemia
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Incidence of Serious Adverse Events, Pneumonitis, Infection and Sepsis in Patients with Relapsed and Refractory Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphom...
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Multicenter Phase I Study Combining Venetoclax with Mini-Hyper-CVD in Older Adults with Untreated and Relapsed/Refractory Acute Lymphoblastic Leukemia
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Phase 1b Study Evaluating the Safety and Efficacy of Venetoclax As Monotherapy or in Combination with Azacitidine for the Treatment of Relapsed/Refractory Myelodyspl...
  Jacqueline S Garcia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019